President Biden signed the Further Consolidated Appropriations Act, 2024 (H.R. 2882) into law March 23, to fund the U.S. Departments of Labor, Education and Health and Human Services and their programs for the remainder of federal fiscal year (FY) 2024.
The act includes $47.1 billion for the National Institutes of Health (NIH), $378 million (0.8%) below the FY 2023 enacted level, a direct result of a scheduled reduction in 21st Century Cures funding available to appropriators in FY 2024. The American College of Radiology® (ACR®) advocated in support of NIH increases.
NIH received $300 million in new funding that is reflected in increases to nine institutes and centers. The act also:
The Advanced Research Projects Agency for Health (ARPA-H) received $1.5 billion in funding, the same level as provided in FY 2023. The legislation urges ARPA-H to consider funding research on rare cancers that have low survival rates and little advancement in therapeutics.
Another provision of the act supported by ACR is an extension of Protecting Access to Lifesaving Screenings (PALS)-type language to ensure access to coverage for annual screening mammography for women 40 and older with no deductibles or copays.
President Biden recently released his FY 2025 budget proposal, in which he requests Congress increase funding for NIH and $716 million in discretionary funds for NCI. Funding for the Cancer Moonshot program was also incorporated into the proposed budget. ACR has begun advocacy efforts for an increase in NIH funding for FY 2025, asking Congress to provide $53.1 billion to NIH.
For more information, contact Katie Grady, ACR Government Affairs Director.
White House Moves to Challenge State AI Laws
White House orders review of state AI laws, pushes for a national framework; agencies may withhold funds over conflicting rules.
Read moreACR Chair Takes Part in IAEA Radiation Protection Conference
ACR Chair Alan Matsumoto, MD, joined global leaders at IAEA conference on radiation protection in medicine.
Read moreElevance Health Defends Policy
ACR signed the AMA letter, co-authored a joint letter with ACEP and ASA, and met with Elevance urging fair contracts for patient benefit.
Read more